Shaneyfelt, T. M., and R. M. Centor. 2009. Reassessment of clinical practice guidelines: Go gently into that good night. JAMA 301(8):868–869.

Shaneyfelt, T., M. Mayo-Smith, and J. Rothwangl. 1999. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature. JAMA 281:1900–1905.

Shekelle, P. G., R. L. Kravitz, J. Beart, M. Marger, M. Wang, and M. Lee. 2000. Are nonspecific practice guidelines potentially harmful? A randomized comparison of the effect of nonspecific versus specific guidelines on physician decision making. Health Services Research 34(7):1429–1448.

Shiffman, R. N., P. Shekelle, J. M. Overhage, J. Slutsky, J. Grimshaw, and A. M. Deshpande. 2003. Standardized reporting of clinical practice guidelines: A proposal from the conference on guideline standardization. Annals of Internal Medicine 139(6):493–498.

SIGN, ed. 2008. SIGN 50: A guideline developer’s handbook. Edinburgh, Scot.: Scottish Intercollegiate Guidelines Network.

Singh, A. K., L. Szczech, K. L. Tang, H. Barnhart, S. Sapp, M. Wolfson, D. Reddan, and C. Investigators. 2006. Correction of anemia with epoetin alfa in chronic kidney disease. New England Journal of Medicine 355(20):2085–2098.

Smith, T. J., and B. E. Hillner. 2001. Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways. Journal of Clinical Oncology 19(11):2886–2897.

Sniderman, A. D., and C. D. Furberg. 2009. Why guideline-making requires reform. JAMA 301(4):429–431.

Steinbrook, R. 2006. Haemoglobin concentrations in chronic kidney disease. The Lancet 368(9554):2191–2193.

Steinbrook, R. 2007. Medicare and erythropoietin. New England Journal of Medicine 356(1):4–6.

Strippoli, G. F., S. D. Navaneethan, and J. C. Craig. 2006. Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease. Cochrane Database of Systematic Reviews (4):CD003967.

Tregear, M. 2007. Guideline heterogeneity; workshop—part 2. Paper presented at The Fourth Annual Guidelines International Network m Haemoglobin concentrations in chronic kidney disease eeting, August 22–25, 2007, Toronto, Canada.

Turner, T., M. Misso, C. Harris, and S. Green. 2008. Development of evidence-based clinical practice guidelines (CPGs): Comparing approaches. Implementation Science 3:45.

USRDS (United States Renal Data System). 2009. USRDS 2009 annual data report: Atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases.

Van Wyck, D., K. U. Eckardt, K. Uhlig, M. Rocco, and A. Levin. 2007. Appraisal of evidence and control of bias in the Kidney Disease Outcomes Quality Initiative guideline development process. Clinical Journal of the American Society of Nephrology 2(1):8–10.

Vlayen, J., B. Aertgeerts, K. Hannes, W. Sermeus, and D. Ramaekers. 2005. A systematic review of appraisal tools for clinical practice guidelines: Multiple similarities and one common deficit. International Journal of Quality Health Care 17(3):235–242.

Wormser, G. P., R. J. Dattwyler, E. D. Shapiro, J. J. Halperin, A. C. Steere, M. S. Klempner, P. J. Krause, J. S. Bakken, F. Strle, G. Stanek, L. Bockenstedt, D. Fish, J. S. Dumler, and R. B. Nadelman. 2006. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clinical Infectious Diseases 43(9):1089–1134.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement